Changes in lipoprotein spectrum in patients with the diagnosis of extremito-vascular ischemic disease;Zmeny v lipoproteínovom spektre pri končatinovo-cievnej ischemickej chorobe

Vnitrni Lekarstvi

Volumn 56, Issue 6, 2010, Pages 620-623

  Oravec, Stanislav ^a   Dukat A ^a   Gavornik P ^a   Caprnda M ^a   Reinoldova O ^a  

^a Il Interná Klinika Lekárskej Fakulty UK   (Slovakia)

Author keywords

Atherogenic lipoproteins; Atherogenic vs non atherogenic lipoprotein profile

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; POLYACRYLAMIDE GEL; LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HIGH RISK POPULATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; PERIPHERAL VASCULAR DISEASE; BLOOD; FEMALE; ISCHEMIA; LEG; MALE; MIDDLE AGED; VASCULARIZATION;

FEMALE; HUMANS; ISCHEMIA; LEG; LIPOPROTEINS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES;

EID: 77954470124     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Superko HR. Lipoprotein subclasses and atherosclerosis. Front Biosci 2001; 6: D355-D365.
2. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-1379.
3. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small dense low-density lipoprotein. Biochem Soc Trans 2003; 31: 1066-1069.
4. Shoji T, Hatsuda S, Tsuchikura S et al. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis 2009; 202: 582-588.
5. Austin MA, King MC, Vranizan KM et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506.
6. Van J, Pan J, Charles MA et al. Atherogenic lipid phenotype in a general group of subjects. Arch Pathol Lab Med 2007; 131: 1679-1685.
7. Hoefner DM, Hodel SD, O'Brien JF et al. Development of a rapid quantitative method for LDL subfraction with use of the Quantimetrix Lipoprint LDL system. Clin Chem 2001; 47: 266-274.
8. Oravec S. Nová laboratórno-medicínska pomoc v diagnostike dyslipoproteínemií a kardiovaskulárnych ochorení: Identifikácia LDL podskupín. Med Milit Slov 2006; 8: 28-32.
9. Oravec S. Identifikácia subpopulácií LDL triedy - Aktuálny prínos v diagnostike porúch metabolizmu lipoproteínov a ochorení kardiovaskulárneho systému. Med Milit Slov 2006; 8: 32-34.
10. Oravec S. Nové perspektívy v diagnostike porúch metabolizmu lipoproteínov - prínos v interpretácii výsledkov. Med Milit Slov 2007; 9: 42-45.
11. Gavorník P. Etiopatogenéza a nová klinicko-etiologicko-anatomicko-patologická (CEAP) klasifikácia končatinovej choroby. Interní Med 2010; 10: 115-123.
12. Gavorník P. Všeobecná angiológia. Angiologická propedeutika. Cievne choroby. Bratislava: Vydavatel'stvo Univerzity Komenského 2001.
13. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease. J Am Coll Cardiol 2006; 47: 1239-1312.
14. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26: 81-157.
15. Vakkilainen J, Mäkimattila S, Seppälä-Lindroos A et al. Endothelial dysfunction in men with small LDL particles. Circulation 2000; 102: 716-721.